NIT Rourkela, IISER Patent Cotarnine Derivative for Oral Cancer

NIT Rourkela, IISER patent cotarnine derivative for oral cancer

BHUBANESWAR: Researchers from the National Institute of Technology Rourkela (NIT Rourkela) and the Indian Institute of Science Education and Research (IISER) Berhampur have developed a novel cotarnine-derived formulation that has shown anticancer activity against oral cancer cells and has now received an Indian patent. The research brings together scientists from the Departments of Chemistry and Life Science at NIT Rourkela and the Department of…

NIT Rourkela Researchers Patent Cotarnine Derivative For Oral Cancer Therapy

Rourkela: Researchers from the National Institute of Technology Rourkela (NIT Rourkela), and the Department of Chemistry, IISER Berhampur, have developed a novel cotarnine-derived formulation for oral cancer treatment. The research work integrates medicinal chemistry with formulation science, with the promising candidate now getting ready for further preclinical investigation and translational research. The innovative formulation has been grante…